5,259 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Bought by Mufg Securities Americas Inc.

Mufg Securities Americas Inc. purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 5,259 shares of the medical equipment provider's stock, valued at approximately $2,745,000.

Several other institutional investors have also modified their holdings of the stock. Bennett Selby Investments LP raised its holdings in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after purchasing an additional 17 shares during the period. Onefund LLC raised its holdings in shares of Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after purchasing an additional 18 shares during the period. LVW Advisors LLC raised its holdings in shares of Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. raised its holdings in shares of Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after purchasing an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC raised its holdings in shares of Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock worth $542,000 after purchasing an additional 19 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. Barclays cut their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Wells Fargo & Company raised their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Piper Sandler dropped their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Citigroup raised their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a report on Friday, January 24th. Finally, Leerink Partners raised their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $598.95.

Intuitive Surgical Trading Up 0.6%

ISRG stock traded up $3.32 during midday trading on Friday, hitting $563.60. 1,422,176 shares of the company's stock were exchanged, compared to its average volume of 1,640,855. Intuitive Surgical, Inc. has a 12-month low of $393.98 and a 12-month high of $616.00. The firm has a 50 day moving average price of $505.22 and a 200-day moving average price of $536.45. The stock has a market capitalization of $202.00 billion, a price-to-earnings ratio of 87.93, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the previous year, the business earned $1.50 EPS. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 2,401 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total value of $1,394,981.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company's stock, valued at approximately $205,093. The trade was a 87.18% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 32,700 shares of company stock worth $16,865,621. 0.70% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.